Racial and ethnic minorities are under-represented in many clinical trials because of less awareness of and access to clinical trials; a lack of direct recruitment due to provider bias; financial, transportation, and childcare burdens; language barriers; and misunderstandings about clinical research.

Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials. Additionally, racial and ethnic minorities may experience unanticipated side effects and lack of efficacy after drug approval if they aren’t included in clinical trials.

This webinar will address:

  • Who is participating in clinical trials and why
  • Why diversity in clinical research is important for ethical, scientific, and financial reasons
  • Solutions on what sponsors, CROs, and investigators/clinical sites can do to increase diversity

Featured Speakers

Yael Symes, PhD

Integrated Product Development Associate

Dr. Symes has over 10 years of experience in writing and editing scientific documents, including 9 publications in peer-reviewed journals. She has participated in the authoring and preparation of clinical protocols, modules of NDAs and INDs, clinical study reports, and other regulatory documents. Her therapeutic area experience includes ophthalmology, infectious diseases, respiratory diseases, and oncology.  Her background public health focuses on patient advocacy, cancer survivorship, and social determinants of health. 

Jack Modell, MD

Vice President & Senior Medical Officer

Dr. Modell is a board-certified psychiatrist with over 35 years of experience in clinical research, including 20 years in academia teaching, providing patient care, and conducting clinical trials, as well as 18 additional years of experience in clinical drug development, medical affairs, successful NDA filings, medical governance, drug safety, compliance, and management within the pharmaceutical and CRO industries. Dr. Modell’s specialties and expertise include neuroscience, pharmacology, drug development, clinical research, medical governance, and clinical diagnosis and treatment. 


Register now for this webinar